摘要
血管紧张素受体拮抗剂对肾素血管紧张素系统终端受体的阻断具有较血管紧张素转换酶抑制剂更好的耐受而逐步广泛地应用于临床。本文综述了坎地沙坦在降压、靶器官保护、防治心力衰竭以及冠心病中的近期研究成果。
AngiotensinⅡreceptor blockades which block the terminal receptor of the renin angiotensin system is applied by clinician gradually and widely because of the better toleration than angiotensin converting enzyme inhibitor.This review sums up the recent result about candesartan in lowering blood pressure,protecting target organ,treating congestive heart failure and coronary heart disease.
出处
《心血管病学进展》
CAS
2004年第3期172-175,共4页
Advances in Cardiovascular Diseases
